abstract |
The present invention relates to a method for monitoring differential gene expression of a biomarker to determine the sensitivity of a patient to a human double microchromosome inhibitor (MDM2i), the sensitivity of a cell to MDM2i by measuring the biomarker. Methods of determining and screening for candidate MDM2i are provided. |